Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
· cnbc.com · popularity 37/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at cnbc.com →
Summary
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
Found in: CNBC Top News. Rating basis: single outlet; outlet tier 5; 1 feeds; feed position 12.